Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cells ‘could be used as an alternative to antibiotics’
"...MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Study finds MSCs in horses fight bacterial infection 

Stem cells found in horses naturally produce molecules that can fight bacterial infection, according to new research by the Roslin Institute.

The team examined mesenchymal stem cells (MSCs), which are seen in animals and humans and can differentiate into a variety of cell types.

They discovered that MSCs may be able to fight infection in two ways - by acting directly on bacteria and by regulating the activity of immune cells involved in the body’s natural defences.

The endometrium was identified as a particularly promising novel source of MSCs for clinical applications in horses - and likely in other species too.

MSCs obtained from bone marrow or adipose tissue have been used for clinical tissue regeneration in animals for more than 10 years, which scientists say assures their safe use as potential clinical antimicrobials in the future.

Lead author Dr Cristina Esteves said: “This study shows that equine MSCs may act to defend the body against bacterial infection.

"We’re excited about these results as MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.